Medical Care
Global Tumor Genomics Market Research Report 2025
- Jul 08, 25
- ID: 348482
- Pages: 87
- Figures: 81
- Views: 40
The global market for Tumor Genomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
North American market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor Genomics in Diagnostics and Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics.
The Tumor Genomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Segment by Type
Assays and Kits
Instrument
Segment by Application
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Genomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
North American market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor Genomics in Diagnostics and Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics.
The Tumor Genomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Segment by Type
Assays and Kits
Instrument
Segment by Application
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Genomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomics Market Perspective (2020-2031)
2.2 Global Tumor Genomics Growth Trends by Region
2.2.1 Global Tumor Genomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Genomics Historic Market Size by Region (2020-2025)
2.2.3 Tumor Genomics Forecasted Market Size by Region (2026-2031)
2.3 Tumor Genomics Market Dynamics
2.3.1 Tumor Genomics Industry Trends
2.3.2 Tumor Genomics Market Drivers
2.3.3 Tumor Genomics Market Challenges
2.3.4 Tumor Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Revenue
3.1.1 Global Top Tumor Genomics Players by Revenue (2020-2025)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomics Market Concentration Ratio
3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2024
3.5 Global Key Players of Tumor Genomics Head office and Area Served
3.6 Global Key Players of Tumor Genomics, Product and Application
3.7 Global Key Players of Tumor Genomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type
4.1 Global Tumor Genomics Historic Market Size by Type (2020-2025)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2026-2031)
5 Tumor Genomics Breakdown Data by Application
5.1 Global Tumor Genomics Historic Market Size by Application (2020-2025)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Genomics Market Size (2020-2031)
6.2 North America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Genomics Market Size by Country (2020-2025)
6.4 North America Tumor Genomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Genomics Market Size (2020-2031)
7.2 Europe Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Genomics Market Size by Country (2020-2025)
7.4 Europe Tumor Genomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Genomics Market Size (2020-2031)
8.2 Asia-Pacific Tumor Genomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Genomics Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Genomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Genomics Market Size (2020-2031)
9.2 Latin America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Genomics Market Size by Country (2020-2025)
9.4 Latin America Tumor Genomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Genomics Market Size (2020-2031)
10.2 Middle East & Africa Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Genomics Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Genomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tumor Genomics Introduction
11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Tumor Genomics Introduction
11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2020-2025)
11.4.5 Danaher Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Details
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Tumor Genomics Introduction
11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025)
11.6.5 Fluidigm Corporation Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Details
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Tumor Genomics Introduction
11.7.4 General Electric Company Revenue in Tumor Genomics Business (2020-2025)
11.7.5 General Electric Company Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Tumor Genomics Introduction
11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.8.5 Illumina, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Tumor Genomics Introduction
11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2020-2025)
11.9.5 Merck KGaA Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Details
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Details
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Tumor Genomics Introduction
11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2020-2025)
11.12.5 PerkinElmer Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Tumor Genomics Introduction
11.13.4 QIAGEN Revenue in Tumor Genomics Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 Siemens Healthineers AG
11.14.1 Siemens Healthineers AG Company Details
11.14.2 Siemens Healthineers AG Business Overview
11.14.3 Siemens Healthineers AG Tumor Genomics Introduction
11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025)
11.14.5 Siemens Healthineers AG Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomics Market Perspective (2020-2031)
2.2 Global Tumor Genomics Growth Trends by Region
2.2.1 Global Tumor Genomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Genomics Historic Market Size by Region (2020-2025)
2.2.3 Tumor Genomics Forecasted Market Size by Region (2026-2031)
2.3 Tumor Genomics Market Dynamics
2.3.1 Tumor Genomics Industry Trends
2.3.2 Tumor Genomics Market Drivers
2.3.3 Tumor Genomics Market Challenges
2.3.4 Tumor Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Revenue
3.1.1 Global Top Tumor Genomics Players by Revenue (2020-2025)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomics Market Concentration Ratio
3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2024
3.5 Global Key Players of Tumor Genomics Head office and Area Served
3.6 Global Key Players of Tumor Genomics, Product and Application
3.7 Global Key Players of Tumor Genomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type
4.1 Global Tumor Genomics Historic Market Size by Type (2020-2025)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2026-2031)
5 Tumor Genomics Breakdown Data by Application
5.1 Global Tumor Genomics Historic Market Size by Application (2020-2025)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Genomics Market Size (2020-2031)
6.2 North America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Genomics Market Size by Country (2020-2025)
6.4 North America Tumor Genomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Genomics Market Size (2020-2031)
7.2 Europe Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Genomics Market Size by Country (2020-2025)
7.4 Europe Tumor Genomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Genomics Market Size (2020-2031)
8.2 Asia-Pacific Tumor Genomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Genomics Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Genomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Genomics Market Size (2020-2031)
9.2 Latin America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Genomics Market Size by Country (2020-2025)
9.4 Latin America Tumor Genomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Genomics Market Size (2020-2031)
10.2 Middle East & Africa Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Genomics Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Genomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tumor Genomics Introduction
11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Tumor Genomics Introduction
11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2020-2025)
11.4.5 Danaher Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Details
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Tumor Genomics Introduction
11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025)
11.6.5 Fluidigm Corporation Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Details
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Tumor Genomics Introduction
11.7.4 General Electric Company Revenue in Tumor Genomics Business (2020-2025)
11.7.5 General Electric Company Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Tumor Genomics Introduction
11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.8.5 Illumina, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Tumor Genomics Introduction
11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2020-2025)
11.9.5 Merck KGaA Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Details
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Details
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Tumor Genomics Introduction
11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2020-2025)
11.12.5 PerkinElmer Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Tumor Genomics Introduction
11.13.4 QIAGEN Revenue in Tumor Genomics Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 Siemens Healthineers AG
11.14.1 Siemens Healthineers AG Company Details
11.14.2 Siemens Healthineers AG Business Overview
11.14.3 Siemens Healthineers AG Tumor Genomics Introduction
11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025)
11.14.5 Siemens Healthineers AG Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instrument
Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Tumor Genomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor Genomics Market Share by Region (2020-2025)
Table 8. Global Tumor Genomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Tumor Genomics Market Share by Region (2026-2031)
Table 10. Tumor Genomics Market Trends
Table 11. Tumor Genomics Market Drivers
Table 12. Tumor Genomics Market Challenges
Table 13. Tumor Genomics Market Restraints
Table 14. Global Tumor Genomics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Tumor Genomics Market Share by Players (2020-2025)
Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Tumor Genomics, Headquarters and Area Served
Table 20. Global Key Players of Tumor Genomics, Product and Application
Table 21. Global Key Players of Tumor Genomics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Genomics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2020-2025)
Table 25. Global Tumor Genomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Tumor Genomics Revenue Market Share by Type (2026-2031)
Table 27. Global Tumor Genomics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Tumor Genomics Revenue Market Share by Application (2020-2025)
Table 29. Global Tumor Genomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Tumor Genomics Revenue Market Share by Application (2026-2031)
Table 31. North America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Tumor Genomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Tumor Genomics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Company Details
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Tumor Genomics Product
Table 49. Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Agilent Technologies, Inc Company Details
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics Product
Table 54. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Details
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Danaher Corporation Company Details
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Tumor Genomics Product
Table 64. Danaher Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. F. Hoffmann-La Roche Ltd Company Details
Table 67. F. Hoffmann-La Roche Ltd Business Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Product
Table 69. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd Recent Development
Table 71. Fluidigm Corporation Company Details
Table 72. Fluidigm Corporation Business Overview
Table 73. Fluidigm Corporation Tumor Genomics Product
Table 74. Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 75. Fluidigm Corporation Recent Development
Table 76. General Electric Company Company Details
Table 77. General Electric Company Business Overview
Table 78. General Electric Company Tumor Genomics Product
Table 79. General Electric Company Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 80. General Electric Company Recent Development
Table 81. Illumina, Inc. Company Details
Table 82. Illumina, Inc. Business Overview
Table 83. Illumina, Inc. Tumor Genomics Product
Table 84. Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 85. Illumina, Inc. Recent Development
Table 86. Merck KGaA Company Details
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Tumor Genomics Product
Table 89. Merck KGaA Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 90. Merck KGaA Recent Development
Table 91. Myriad Genetics, Inc. Company Details
Table 92. Myriad Genetics, Inc. Business Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Product
Table 94. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 95. Myriad Genetics, Inc. Recent Development
Table 96. Pacific Biosciences of California, Inc. Company Details
Table 97. Pacific Biosciences of California, Inc. Business Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Product
Table 99. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc. Recent Development
Table 101. PerkinElmer Company Details
Table 102. PerkinElmer Business Overview
Table 103. PerkinElmer Tumor Genomics Product
Table 104. PerkinElmer Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 105. PerkinElmer Recent Development
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Tumor Genomics Product
Table 109. QIAGEN Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Siemens Healthineers AG Company Details
Table 112. Siemens Healthineers AG Business Overview
Table 113. Siemens Healthineers AG Tumor Genomics Product
Table 114. Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 115. Siemens Healthineers AG Recent Development
Table 116. Thermo Fisher Scientific Inc. Company Details
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Product
Table 119. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 120. Thermo Fisher Scientific Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Tumor Genomics Picture
Figure 2. Global Tumor Genomics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Genomics Market Share by Type: 2024 VS 2031
Figure 4. Assays and Kits Features
Figure 5. Instrument Features
Figure 6. Global Tumor Genomics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Tumor Genomics Market Share by Application: 2024 VS 2031
Figure 8. Diagnostics and Monitoring Case Studies
Figure 9. Drug Discovery and Development Case Studies
Figure 10. Biomarker Discovery Case Studies
Figure 11. Tumor Genomics Report Years Considered
Figure 12. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Tumor Genomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tumor Genomics Market Share by Region: 2024 VS 2031
Figure 15. Global Tumor Genomics Market Share by Players in 2024
Figure 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2024
Figure 18. North America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Tumor Genomics Market Share by Country (2020-2031)
Figure 20. United States Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tumor Genomics Market Share by Country (2020-2031)
Figure 24. Germany Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tumor Genomics Market Share by Region (2020-2031)
Figure 32. China Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tumor Genomics Market Share by Country (2020-2031)
Figure 40. Mexico Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tumor Genomics Market Share by Country (2020-2031)
Figure 44. Turkey Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 48. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 50. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 52. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 53. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 54. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 57. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 58. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 59. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 60. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instrument
Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Tumor Genomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor Genomics Market Share by Region (2020-2025)
Table 8. Global Tumor Genomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Tumor Genomics Market Share by Region (2026-2031)
Table 10. Tumor Genomics Market Trends
Table 11. Tumor Genomics Market Drivers
Table 12. Tumor Genomics Market Challenges
Table 13. Tumor Genomics Market Restraints
Table 14. Global Tumor Genomics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Tumor Genomics Market Share by Players (2020-2025)
Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Tumor Genomics, Headquarters and Area Served
Table 20. Global Key Players of Tumor Genomics, Product and Application
Table 21. Global Key Players of Tumor Genomics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Genomics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2020-2025)
Table 25. Global Tumor Genomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Tumor Genomics Revenue Market Share by Type (2026-2031)
Table 27. Global Tumor Genomics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Tumor Genomics Revenue Market Share by Application (2020-2025)
Table 29. Global Tumor Genomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Tumor Genomics Revenue Market Share by Application (2026-2031)
Table 31. North America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Tumor Genomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Tumor Genomics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Company Details
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Tumor Genomics Product
Table 49. Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Agilent Technologies, Inc Company Details
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics Product
Table 54. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Details
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Danaher Corporation Company Details
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Tumor Genomics Product
Table 64. Danaher Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. F. Hoffmann-La Roche Ltd Company Details
Table 67. F. Hoffmann-La Roche Ltd Business Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Product
Table 69. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd Recent Development
Table 71. Fluidigm Corporation Company Details
Table 72. Fluidigm Corporation Business Overview
Table 73. Fluidigm Corporation Tumor Genomics Product
Table 74. Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 75. Fluidigm Corporation Recent Development
Table 76. General Electric Company Company Details
Table 77. General Electric Company Business Overview
Table 78. General Electric Company Tumor Genomics Product
Table 79. General Electric Company Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 80. General Electric Company Recent Development
Table 81. Illumina, Inc. Company Details
Table 82. Illumina, Inc. Business Overview
Table 83. Illumina, Inc. Tumor Genomics Product
Table 84. Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 85. Illumina, Inc. Recent Development
Table 86. Merck KGaA Company Details
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Tumor Genomics Product
Table 89. Merck KGaA Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 90. Merck KGaA Recent Development
Table 91. Myriad Genetics, Inc. Company Details
Table 92. Myriad Genetics, Inc. Business Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Product
Table 94. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 95. Myriad Genetics, Inc. Recent Development
Table 96. Pacific Biosciences of California, Inc. Company Details
Table 97. Pacific Biosciences of California, Inc. Business Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Product
Table 99. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc. Recent Development
Table 101. PerkinElmer Company Details
Table 102. PerkinElmer Business Overview
Table 103. PerkinElmer Tumor Genomics Product
Table 104. PerkinElmer Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 105. PerkinElmer Recent Development
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Tumor Genomics Product
Table 109. QIAGEN Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Siemens Healthineers AG Company Details
Table 112. Siemens Healthineers AG Business Overview
Table 113. Siemens Healthineers AG Tumor Genomics Product
Table 114. Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 115. Siemens Healthineers AG Recent Development
Table 116. Thermo Fisher Scientific Inc. Company Details
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Product
Table 119. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)
Table 120. Thermo Fisher Scientific Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Tumor Genomics Picture
Figure 2. Global Tumor Genomics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Genomics Market Share by Type: 2024 VS 2031
Figure 4. Assays and Kits Features
Figure 5. Instrument Features
Figure 6. Global Tumor Genomics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Tumor Genomics Market Share by Application: 2024 VS 2031
Figure 8. Diagnostics and Monitoring Case Studies
Figure 9. Drug Discovery and Development Case Studies
Figure 10. Biomarker Discovery Case Studies
Figure 11. Tumor Genomics Report Years Considered
Figure 12. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Tumor Genomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tumor Genomics Market Share by Region: 2024 VS 2031
Figure 15. Global Tumor Genomics Market Share by Players in 2024
Figure 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2024
Figure 18. North America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Tumor Genomics Market Share by Country (2020-2031)
Figure 20. United States Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tumor Genomics Market Share by Country (2020-2031)
Figure 24. Germany Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tumor Genomics Market Share by Region (2020-2031)
Figure 32. China Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tumor Genomics Market Share by Country (2020-2031)
Figure 40. Mexico Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tumor Genomics Market Share by Country (2020-2031)
Figure 44. Turkey Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 48. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 50. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 52. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 53. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 54. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 57. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 58. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 59. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 60. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232